- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 453/06 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing iso-quinuclidine ring systems
Patent holdings for IPC class C07D 453/06
Total number of patents in this class: 70
10-year publication summary
|
5
|
5
|
4
|
5
|
4
|
0
|
8
|
0
|
4
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Demerx, Inc. | 76 |
9 |
| The University of Melbourne | 569 |
4 |
| Philip Morris Products S.A. | 8181 |
3 |
| Achillion Pharmaceuticals, Inc. | 157 |
3 |
| Nxera Pharma UK Limited | 189 |
3 |
| Boehringer Ingelheim International GmbH | 4493 |
2 |
| The Trustees of Columbia University in the City of New York | 3644 |
2 |
| Banyu Pharmaceutical Co., Ltd. | 44 |
2 |
| MSD K.K. | 65 |
2 |
| Rottapharm Biotech S.r.l. | 42 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3304 |
2 |
| Aligos Therapeutics, Inc. | 163 |
2 |
| Sumitomo Pharma Co., Ltd. | 555 |
2 |
| Recludix Pharma, Inc. | 16 |
2 |
| Bristol-myers Squibb Company | 4742 |
1 |
| F. Hoffmann-La Roche AG | 7837 |
1 |
| Hoffmann-La Roche Inc. | 3793 |
1 |
| AstraZeneca AB | 2814 |
1 |
| AstraZeneca UK Limited | 528 |
1 |
| Bayer AG | 3501 |
1 |
| Other owners | 24 |